Adcirca tablets — Cigna
Pulmonary arterial hypertension (PAH) (WHO Group I)
Preferred products
- generic tadalafil tablets (20 mg)
- Alyq
Initial criteria
- Patient meets the standard Pulmonary Arterial Hypertension – Phosphodiesterase Type 5 Inhibitors Prior Authorization Policy criteria
- Patient has tried Alyq or generic tadalafil 20 mg tablets [documentation required or verification of prescription claims history required]
- Patient cannot continue to use generic tadalafil 20 mg tablets due to a formulation difference in the inactive ingredient(s) (e.g., dyes, fillers, preservatives) between the Brand and the bioequivalent product which, per the prescriber, would result in a significant allergy or serious adverse reaction
Approval duration
1 year